BRAF, MEK, and EGFR Triplet Inhibitors as Salvage Therapy in BRAF-Mutated Metastatic Colorectal Cancer-A Case Series Study Target Therapy of BRAF-Mutated mCRC.
Medicina (Kaunas)
; 57(12)2021 Dec 07.
Article
en En
| MEDLINE
| ID: mdl-34946284
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Neoplasias Colorrectales
/
Terapia Recuperativa
Límite:
Humans
Idioma:
En
Año:
2021
Tipo del documento:
Article